CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
0.8300
+0.1040 (14.33%)
At close: Mar 13, 2026, 4:00 PM EDT
0.8300
0.00 (0.00%)
Pre-market: Mar 16, 2026, 6:43 AM EDT
CalciMedica Stock Forecast
CALC's stock price has decreased by -56.77% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for CalciMedica stock has a target of 10, which predicts a 1,104.82% increase from the current stock price of 0.83.
Price Target: $10 (+1,104.82%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CalciMedica stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $20 → $10 | Buy | Maintains | $20 → $10 | +1,104.82% | Mar 5, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 29, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +1,827.71% | May 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +1,827.71% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +1,827.71% | Mar 4, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
6.80M
EPS This Year
-1.60
from -1.97
EPS Next Year
-2.14
from -1.60
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | n/a | 21.0M |
| Avg | n/a | 6.8M |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -0.96 | -1.11 |
| Avg | -1.60 | -2.14 |
| Low | -2.10 | -2.93 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.